Dentsply Sirona Inc. (XRAY): Price and Financial Metrics

XRAY POWR Grades

• XRAY scores best on the Growth dimension, with a Growth rank ahead of 98.27% of US stocks.
• The strongest trend for XRAY is in Quality, which has been heading down over the past 48 weeks.
• XRAY ranks lowest in Stability; there it ranks in the 50th percentile.

XRAY Stock Summary

• DENTSPLY SIRONA Inc's market capitalization of $13,056,212,904 is ahead of 83.9% of US-listed equities.
• With a one year PEG ratio of 1.88, DENTSPLY SIRONA Inc is expected to have a higher PEG ratio (a measure of how expensive a stock is relative to its expected earnings growth) than just 9.25% of US stocks.
• Over the past twelve months, XRAY has reported earnings growth of 1,889.14%, putting it ahead of 98.68% of US stocks in our set.
• If you're looking for stocks that are quantitatively similar to DENTSPLY SIRONA Inc, a group of peers worth examining would be SWBI, RL, FOE, SMED, and GOLF.
• XRAY's SEC filings can be seen here. And to visit DENTSPLY SIRONA Inc's official web site, go to www.dentsplysirona.com.

XRAY Valuation Summary

• XRAY's EV/EBIT ratio is 29.3; this is 0% higher than that of the median Healthcare stock.
• XRAY's price/sales ratio has moved up 0.8 over the prior 243 months.
• Over the past 243 months, XRAY's price/sales ratio has gone up 0.8.

Below are key valuation metrics over time for XRAY.

XRAY Growth Metrics

• Its 4 year revenue growth rate is now at 41.81%.
• Its 5 year cash and equivalents growth rate is now at -0.21%.
• Its 5 year price growth rate is now at -33.76%.

Over the past 52 months, XRAY's revenue has gone up $197,900,000.

The table below shows XRAY's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2021-06-30	4,071.1	733.6	368.3
2021-03-31	3,494.7	694.7	173.9
2020-12-31	3,342	635	-83
2020-09-30	3,371.2	670.8	-79.2
2020-06-30	3,438.5	622.8	-48
2020-03-31	3,957.3	592.8	83.8

XRAY's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• XRAY has a Quality Grade of C, ranking ahead of 67.05% of graded US stocks.
• XRAY's asset turnover comes in at 0.443 -- ranking 107th of 182 Medical Equipment stocks.
• TFX, ZBH, and PEN are the stocks whose asset turnover ratios are most correlated with XRAY.

The table below shows XRAY's key quality metrics over time.